Status:

RECRUITING

The Effectiveness of Chuna Maintenance Therapy for Chronic Bothersome Neck Pain

Lead Sponsor:

Jaseng Medical Foundation

Conditions:

Neck Pain

Chronic Pain

Eligibility:

All Genders

19-70 years

Phase:

NA

Brief Summary

This study is a pragmatic randomized controlled study that assessed 250 subjects complaining of chronic bothersome neck pain with mild discomfort in a 1:1 ratio: chuna maintenance therapy group (125 s...

Eligibility Criteria

Inclusion

  • Aged 19 or older but under 70.
  • Neck pain with pain duration of 12 months or longer
  • NRS of neck pain over the past month is 2 or more but less than 4
  • Patients who have agreed to trial participation and provided written informed consent

Exclusion

  • Patients diagnosed with serious pathology(s) which may cause neck pain (e.g. spinal metastasis of tumor(s), acute fracture, spinal dislocation)
  • Patients with progressive neurologic deficit or severe neurologic symptoms such as spinal cord injury
  • Patients whose pain is due to soft tissue disease not the spine (e.g. tumors, fibromyalgia, rheumatoid arthritis, gout)
  • Patients with other chronic disease(s) which may interfere with treatment effect, safety, or interpretation of outcome (e.g. stroke and myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy)
  • Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results
  • Pregnant patients or patients with plans of pregnancy or lactating patients
  • Patients within 3 months after cervical surgery
  • Patients with experience of participating in another clinical study within 1 month or plan to participate in another clinical study during the study participation and follow-up period within 6 months from the participation date
  • Patients having difficult to completing the written informed consent
  • Patients who are deemed unsuitable by the researchers

Key Trial Info

Start Date :

July 7 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT06591221

Start Date

July 7 2024

End Date

December 31 2025

Last Update

September 4 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Bucheon Jaseng Hospital of Korean Medicine

Bucheon-si, South Korea

2

Daejeon Jaseng Hospital of Korean Medicine

Daejeon, South Korea

3

Haeundae Jaseng Hospital of Korean Medicine

Haeundae, South Korea

4

College of Korean Medicine, Kyung Hee University

Seoul, South Korea